MK-2866 Solution, 30mg/ml

MK-2866 Solution, 30mg/ml

AUD$149.00

 

Note: Products are for laboratory research use only. Not for human use. Reference Materials are not therapeutics and we do not sell to patients.

 

Out of stock

Category:
000
CAS 841205-47-8
Molar Mass 389.33 g/mol
Chemical Formula C19H14F3N3O3
IUPAC Name ((2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide)
Synonyms Ostarine, Enobosarm, GTx-024, MK-2866
Storage Room temperature
Country of Origin USA
Standard 30mg/mL ±10%
Terms of sale This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Information presented is based upon evidence found in clinical studies. Research products sold on this site are not bound by the ‘Therapeutic Goods Act of 1989’. Please familiarise yourself with our Terms & Conditions prior to ordering.

Ostarine (MK2866) was first developed to prevent muscle wastage in cancer patients and people with osteoporosis. Ostarine (MK2866) works by binding to the Androgen Receptor, increasing protein synthesis and altering the expression of genes. It almost exclusively exerts its anabolic effects on the muscle tissues and minimizes muscle atrophy, most notably during recovery periods from surgery and injuries. For this reason it can be favoured for its ability to heal muscle injuries due to its healing properties.
Ostarine (MK2866) is highly anabolic, even at moderate doses making it very effective at building lean mass gains.

In Vivo:
Studies of Ostarine (MK2866) suggest dosage to be around 30mg per day.

Studies and additional info:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602589/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039881/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811355/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039881/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072878/